Cargando…
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors
BACKGROUND & AIMS: In patients with autoimmune atrophic gastritis and achlorhydria, hypergastrinemia is associated with the development of type 1 gastric neuroendocrine tumors (gNETs). Twelve months of treatment with netazepide (YF476), an antagonist of the cholecystokinin B receptor (CCKBR or C...
Autores principales: | Lloyd, Katie A., Parsons, Bryony N., Burkitt, Michael D., Moore, Andrew R., Papoutsopoulou, Stamatia, Boyce, Malcolm, Duckworth, Carrie A., Exarchou, Klaire, Howes, Nathan, Rainbow, Lucille, Fang, Yongxiang, Oxvig, Claus, Dodd, Steven, Varro, Andrea, Hall, Neil, Pritchard, D. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215182/ https://www.ncbi.nlm.nih.gov/pubmed/32004755 http://dx.doi.org/10.1016/j.jcmgh.2020.01.010 |
Ejemplares similares
-
Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
por: Moore, Andrew R., et al.
Publicado: (2013) -
Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
por: Moore, Andrew R., et al.
Publicado: (2013) -
New Developments in Gastric Neuroendocrine Neoplasms
por: Exarchou, Klaire, et al.
Publicado: (2022) -
Lactation opposes pappalysin‐1‐driven pregnancy‐associated breast cancer
por: Takabatake, Yukie, et al.
Publicado: (2016) -
Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use
por: Parsons, Bryony N., et al.
Publicado: (2017)